M55Remark Code (RARC)Active
M55 Remark Code - Self-Administered Anti-Emetics Denial
The M55 remark code indicates that payment is not made for self-administered anti-emetic drugs unless they are given in conjunction with a covered oral anti-cancer drug. This means that the claim was denied based on the payer's policy regarding specific drug administration requirements.
How It Relates to the Denial
The M55 code typically accompanies adjustment reason codes related to drug coverage denials or exclusions. Together, they signal that the billed anti-emetic drugs did not meet the criteria for reimbursement due to the absence of a related covered anti-cancer drug.
Common Scenarios
1A claim was submitted for a self-administered anti-emetic drug prescribed for a patient undergoing chemotherapy. The remittance advice returned with a denial for the drug.
→ The M55 remark code suggests that the payer does not cover the anti-emetic because it was not administered alongside a covered oral anti-cancer drug, indicating a policy on drug pairing.
2A provider billed for an anti-emetic drug on its own without including any related oral anti-cancer medications. The remittance response included an adjustment reason code along with the M55 remark.
→ The appearance of the M55 remark indicates that the payer's policy excludes payment for the anti-emetic in the absence of a covered oral anti-cancer drug.
3A patient receiving treatment for cancer was prescribed a self-administered anti-emetic but did not receive a covered oral anti-cancer drug. The claim was submitted and subsequently denied.
→ The M55 remark code confirms that the denial is due to the specific requirement that the anti-emetic must be administered with a covered oral anti-cancer drug for reimbursement.
What to Do
- Review the claim to confirm whether a covered oral anti-cancer drug was billed alongside the self-administered anti-emetic drug. If not, consider the implications of the payer's policy on future claims.
- If a covered oral anti-cancer drug was included, gather documentation to support that it was administered and prepare to appeal the denial with the necessary evidence.
What to Check
- The claim details to verify the inclusion of any oral anti-cancer drugs.
- Payer policy documents regarding drug coverage and administration requirements for anti-emetic drugs.
- The patient's medical records to confirm the treatment protocol and any administered medications.